<VariationArchive VariationID="2092113" VariationName="NM_007217.4(PDCD10):c.529dup (p.Thr177fs)" VariationType="Duplication" Accession="VCV002092113" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2152611" VariationID="2092113">
      <GeneList>
        <Gene Symbol="PDCD10" FullName="programmed cell death 10" GeneID="11235" HGNC_ID="HGNC:8761" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="167683298" stop="167734892" display_start="167683298" display_stop="167734892" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="167401693" stop="167452650" display_start="167401693" display_stop="167452650" Strand="-" />
          </Location>
          <OMIM>609118</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_007217.4(PDCD10):c.529dup (p.Thr177fs)</Name>
      <CanonicalSPDI>NC_000003.12:167687261:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="167687261" stop="167687262" display_start="167687261" display_stop="167687262" variantLength="1" positionVCF="167687261" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="167405049" stop="167405050" display_start="167405049" display_stop="167405050" variantLength="1" positionVCF="167405049" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>T177fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_651" sequenceAccession="LRG_651">
            <Expression>LRG_651:g.52602dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_651t1" sequenceAccession="LRG_651t1">
            <Expression>LRG_651t1:c.529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_651p1" sequenceAccession="LRG_651p1" change="p.Thr177fs">
            <Expression>LRG_651p1:p.Thr177fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.167405050dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.167405050dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.167687262dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.167687262dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008158.1" sequenceAccession="NG_008158" sequenceVersion="1" change="g.52602dup">
            <Expression>NG_008158.1:g.52602dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007217.4" sequenceAccession="NM_007217" sequenceVersion="4" change="c.529dup" MANESelect="true">
            <Expression>NM_007217.4:c.529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009148.2" sequenceAccession="NP_009148" sequenceVersion="2" change="p.Thr177fs">
            <Expression>NP_009148.2:p.Thr177fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145859.2" sequenceAccession="NM_145859" sequenceVersion="2" change="c.529dup">
            <Expression>NM_145859.2:c.529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_665858.1" sequenceAccession="NP_665858" sequenceVersion="1" change="p.Thr177fs">
            <Expression>NP_665858.1:p.Thr177fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145860.2" sequenceAccession="NM_145860" sequenceVersion="2" change="c.529dup">
            <Expression>NM_145860.2:c.529dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_665859.1" sequenceAccession="NP_665859" sequenceVersion="1" change="p.Thr177fs">
            <Expression>NP_665859.1:p.Thr177fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007217.4(PDCD10):c.529dup (p.Thr177fs) AND Cerebral cavernous malformation 3" Accession="RCV003015946" Version="2">
        <ClassifiedConditionList TraitSetID="475">
          <ClassifiedCondition DB="MedGen" ID="C1864040">Cerebral cavernous malformation 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15543491</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30161288</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="475" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="762" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cerebral cavernous malformation 3</ElementValue>
                <XRef ID="MONDO:0011305" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral cavernous malformations 3</ElementValue>
                <XRef ID="Cerebral+cavernous+malformations+3/7939" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CCM3</ElementValue>
                <XRef Type="MIM" ID="603285" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cerebral cavernous malformations (CCMs) are vascular malformations in the brain and spinal cord comprising closely clustered, enlarged capillary channels (caverns) with a single layer of endothelium without mature vessel wall elements or normal intervening brain parenchyma. The diameter of CCMs ranges from a few millimeters to several centimeters. CCMs increase or decrease in size and increase in number over time. Hundreds of lesions may be identified, depending on the person's age and the quality and type of brain imaging used. Although CCMs have been reported in infants and children, the majority become evident between the second and fifth decades with findings such as seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage. Up to 50% of individuals with FCCM remain symptom free throughout their lives. Cutaneous vascular lesions are found in 9% of those with familial cerebral cavernous malformations (FCCM; see Diagnosis/testing) and retinal vascular lesions in almost 5%.</Attribute>
                <XRef ID="NBK1293" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18314" />
                <XRef ID="18314" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301470</ID>
                <ID Source="BookShelf">NBK1293</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHA/ASA, 2014">
                <ID Source="PubMed">25355838</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="221061" DB="Orphanet" />
              <XRef ID="C1864040" DB="MedGen" />
              <XRef ID="MONDO:0011305" DB="MONDO" />
              <XRef Type="MIM" ID="603285" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6002844" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15738643|MedGen:C1864040" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003312655" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15543491</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30161288</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PDCD10 protein in which other variant(s) (p.Arg196*) have been determined to be pathogenic (PMID: 15543491, 30161288). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with PDCD10-related conditions. This sequence change creates a premature translational stop signal (p.Thr177Asnfs*7) in the PDCD10 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 36 amino acid(s) of the PDCD10 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PDCD10" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.167405049_167405050insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864040" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6002844" TraitType="Disease" MappingType="XRef" MappingValue="C1864040" MappingRef="MedGen">
        <MedGen CUI="C1864040" Name="Cerebral cavernous malformation 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

